Mathias Schmidt, Ph.D., has been named CEO of ArmaGen Inc. He also becomes a member of ArmaGen’s board of directors.
Eric Simmerman is now the first chief technology officer for HealthPrize Technologies.
Intouch Solutions and Healthware International signed a definitive agreement to share ownership of a new joint venture that will serve the needs of life science clients worldwide.
In honor of American Heart Month, AHA and OH launch new initiative to improve heart health outcomes.
Registration for the 2017 HBA New York/New Jersey area Group Mentoring Program is open now through 2/28/17.
Aetna and Humana would consider all available options for their proposed $34 billion merger, the two U.S. health insurers said one day after a court ruled against the deal due to fears it would lower competition.
Bristol-Myers Squibb and Ono Pharmaceutical announced a global patent license agreement with Merck & Co. to settle all patent-infringement litigation related to Merck’s PD-1 antibody Keytruda.
Medical startups must successfully mix entrepreneurial knowledge, a STEM-steeped education, and real-life experience to have the type of lasting impact they desire.
PsiOxus Therapeutics Ltd. agreed to grant Bristol-Myers Squibb Co. exclusive worldwide rights to NG-348, a pre-clinical stage, “armed” oncolytic virus with the goal of addressing solid tumors.
For the ninth year, Med Ad News has chosen new Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
